Published in Przegl Lek on January 01, 2002
Absolute quantification of endogenous angiotensin II levels in human plasma using ESI-LC-MS/MS. Clin Proteomics (2014) 0.77
Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J Exp Med (2006) 2.65
Superior early diagnostic performance of a sensitive cardiac troponin assay as compared to a standard troponin test in the diagnosis of acute myocardial infarction. Kardiol Pol (2012) 2.03
Influence of exercise training on left ventricular diastolic function and its relationship to exercise capacity in patients after myocardial infarction. Cardiol J (2010) 1.48
Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up. J Cardiovasc Electrophysiol (2010) 1.45
Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy. Kardiol Pol (2009) 1.41
Prognostic value of novel biomarkers compared with detailed biochemical evaluation in patients with heart failure. Pol Arch Med Wewn (2015) 1.41
Inflammatory response and postoperative kidney failure in patients with diabetes type 2 or impaired glucose tolerance undergoing heart valve surgery. Kardiol Pol (2010) 1.40
Ischaemia modified albumin in patients with acute coronary syndrome and negative cardiac troponin I. Scand J Clin Lab Invest (2013) 1.39
Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy. Kardiol Pol (2010) 1.39
The role of B-type natriuretic peptide in the evaluation of left atrioventricular valve regurgitation following surgical repair of partial atrioventricular canal. Kardiol Pol (2012) 1.38
Cumulative incidence of coronary lesions with vulnerable characteristics in patients with stable angina pectoris: an intravascular ultrasound and angiographic study. Int J Cardiol (2005) 1.38
[Cardiovascular complication of cocaine abuse]. Kardiol Pol (2012) 1.38
Does p.Q247X in TRIM63 cause human hypertrophic cardiomyopathy? Circ Res (2014) 1.24
Sudden death in noncoronary heart disease is associated with delayed paced ventricular activation. Circulation (2003) 1.09
Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol Pol (2007) 1.03
A case report of Noonan's syndrome with pulmonary valvar stenosis and coronary aneurysms. Med Sci Monit (2004) 0.96
Association of non-specific inflammatory activation with early mortality in patients with ST-elevation acute coronary syndrome treated with primary angioplasty. Circ J (2008) 0.95
Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis. J Hypertens (2007) 0.94
[Percutaneous coronary interventions. Guidelines of the European Society of Cardiology-ESC]. Kardiol Pol (2005) 0.93
Decreased plasma concentration of a novel anti-inflammatory protein--adiponectin--in hypertensive men with coronary artery disease. Thromb Res (2003) 0.88
[POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities]. Kardiol Pol (2009) 0.88
[Ablation of atypical, fast atrio-ventricular nodal tachycardia in a pregnant woman--a case report]. Kardiol Pol (2006) 0.88
Alteration of myocardial sarcoplasmic reticulum Ca2+-ATPase and Na+-Ca2+ exchanger expression in human left ventricular volume overload. Eur J Heart Fail (2007) 0.87
Autophagy in transition from hypertrophic cardiomyopathy to heart failure. J Electron Microsc (Tokyo) (2009) 0.87
The clinical course and risk in patients with pseudo-Mahaim fibers. Cardiol J (2008) 0.87
Femoral rather than carotid artery ultrasound imaging predicts extent and severity of coronary artery disease. Kardiol Pol (2007) 0.86
The BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation. J Transl Med (2014) 0.86
Antioxidative activity of sulodexide, a glycosaminoglycan, in patients with stable coronary artery disease: a pilot study. Med Sci Monit (2009) 0.86
Ultrastructural evidence of myocardial capillary remodeling in peripartum cardiomyopathy. Med Sci Monit (2010) 0.86
Primary angioplasty in patients > or = 75 years old with ST-elevation myocardial infarction - one-year follow-up results. Kardiol Pol (2008) 0.85
Hepatocyte growth factor--a new marker for prognosis in acute coronary syndrome. Growth Factors (2010) 0.85
Concentration of vascular endothelial growth factor in patients with acute coronary syndrome. Cytokine (2013) 0.84
Active lymphocytic myocarditis treated with murine OKT3 monoclonal antibody in a patient presenting with intractable ventricular tachycardia. Tex Heart Inst J (2002) 0.84
Reduced myocardial expression of calcium handling protein in patients with severe chronic mitral regurgitation. Eur J Cardiothorac Surg (2006) 0.84
Adrenomedullin concentrations at two time points following myocardial infarction and prediction of mid-term outcomes. Arch Med Sci (2011) 0.83
Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies. Kardiol Pol (2006) 0.83
Repaired tetralogy of Fallot: ratio of right ventricular volume to left ventricular volume as a marker of right ventricular dilatation. Radiology (2012) 0.82
Obliteration of cardiomyocyte nuclear architecture in a patient with LMNA gene mutation. J Neurol Sci (2008) 0.82
Hemoglobin, leukocytosis and clinical outcomes of ST-elevation myocardial infarction treated with primary angioplasty: ANIN Myocardial Infarction Registry. Circ J (2008) 0.81
Prognostic significance of heart rate variability in dilated cardiomyopathy. Int J Cardiol (2003) 0.81
Impact of diabetes on survival in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the POLISH STEMI registry. Atherosclerosis (2009) 0.81
Epicardial adipose tissue radiodensity is independently related to coronary atherosclerosis. A multidetector computed tomography study. Circ J (2010) 0.80
Significance of dyslipidaemia in patients with heart failure of unexplained aetiology. Kardiol Pol (2008) 0.80
[Transcatheter closure of left atrial appendage with the Amplatzer Cardiac Plug in patients with atrial fibrillation and high risk of thromboembolic events--early experience]. Kardiol Pol (2010) 0.80
White blood cell count adds prognostic information to the thrombolysis in myocardial infarction risk index in patients following primary percutaneous coronary intervention (ANIN Myocardial Infarction Registry). Int J Cardiol (2006) 0.80
LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies. BMC Med Genet (2013) 0.79
Familial form of arrhythmogenic right ventricular cardiomyopathy. Kardiol Pol (2004) 0.79
Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction. Kardiol Pol (2007) 0.79
Cardiac amyloidosis diagnosed by endomyocardial biopsy. Clinical, histopathological, immunohistochemical and ultrastructural studies. Kardiol Pol (2005) 0.79
Late gadolinium enhancement gray zone in patients with hypertrophic cardiomyopathy. Comparison of different gray zone definitions. Int J Cardiovasc Imaging (2010) 0.78
[Echocardiographic assessment of left atrial volume and emptying in hypertrophic cardiomyopathy]. Przegl Lek (2004) 0.78
Usefulness of endothelin-1 concentration in capillary blood in patients with mitral stenosis as a predictor of regression of pulmonary hypertension after mitral valve replacement or valvuloplasty. Am J Cardiol (2002) 0.78
Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Kardiol Pol (2004) 0.78
Alterations in calcium regulatory protein expression in patients with preserved left ventricle systolic function and mitral valve stenosis. J Card Fail (2008) 0.78
Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension. Endokrynol Pol (2013) 0.78
Holter-type impedance cardiography device. A system for continuous and non-invasive monitoring of cardiac haemodynamics. Kardiol Pol (2004) 0.77
Dilated cardiomyopathy with profound segmental wall motion abnormalities and ventricular arrhythmia caused by the R541C mutation in the LMNA gene. Int J Cardiol (2009) 0.77
Usefulness of 1H MR spectroscopy in the evaluation of myocardial metabolism in patients with dilated idiopathic cardiomyopathy: pilot study. Acad Radiol (2003) 0.77
Familial dilated cardiomyopathy: evidence for clinical and immunogenetic heterogeneity. Med Sci Monit (2003) 0.77
Clinically overt and silent cerebral embolism in the course of infective endocarditis. J Neurol (2011) 0.77
[Use of magnetic resonance spectroscopy in cardiology. State of the art]. Przegl Lek (2002) 0.77
Optimization of dose prescription protocol and its impact on delivered dose and vascular response after beta-radiation for in-stent restenosis. A randomized trial with serial volumetric intravascular ultrasound and dose volume histograms. Cardiovasc Revasc Med (2006) 0.77
Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography. Neuroendocrinology (2015) 0.77
Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods. Kardiol Pol (2006) 0.77
Acute myocardial infarction complicated by cardiogenic shock. In-hospital and mid-term results of invasive treatment in the National Institute of Cardiology, Warsaw-Anin. Kardiol Pol (2003) 0.77
Application of classic heart failure definitions of asymptomatic and symptomatic ventricular dysfunction and heart failure symptoms with preserved ejection fraction to patients with systemic right ventricles. Am J Cardiol (2009) 0.77
The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease. Kardiol Pol (2003) 0.76
Gender differences in angiotensin II and aldosterone secretion in patients with pressure overloaded systemic right ventricles are similar to those observed in systemic arterial hypertension. Int J Cardiol (2009) 0.76
A beneficial effect of 3-year spironolactone therapy supplementing atenolol therapy on the remodeling of atria and ventricles in a patient with permanent atrial fibrillation. Intern Emerg Med (2009) 0.76
[Recurrent ventricular fibrillation during a febrile illness as the first manifestation of Brugada syndrome--a case report]. Kardiol Pol (2004) 0.76
Serum tissue inhibitor of metalloproteinases-1 and higher risk features of coronary plaque: a volumetric multivessel intravascular ultrasound study. Atherosclerosis (2006) 0.76
Clustering of admission hyperglycemia, impaired renal function and anemia and its impact on in-hospital outcomes in patients with ST-elevation myocardial infarction. Atherosclerosis (2009) 0.76
A new c.1621 C > G, p.R541G lamin A/C mutation in a family with DCM and regional wall motion abnormalities (akinesis/dyskinesis): genotype-phenotype correlation. J Hum Genet (2010) 0.76
Fibrinogen and smooth muscle cell detection in atherosclerotic plaques from stable and unstable angina -- an immunohistochemical study. Med Sci Monit (2002) 0.76
[Myocardial microabscesses detected by endomyocardial biopsy in a patient with dilated cardiomyopathy and celiac disease: a case report]. Kardiol Pol (2006) 0.75
Impact of percutaneous coronary intervention on biomarker levels in patients in the subacute phase following myocardial infarction: the Occluded Artery Trial (OAT) biomarker ancillary study. BMC Cardiovasc Disord (2013) 0.75
Dilated cardiomyopathy in the postgenomic era. Kardiol Pol (2009) 0.75